Numinus Wellness Inc. (TSX:NUMI)

Market Cap	16.03M -60.5%
Revenue (ttm)	6.49M +11.1%
Net Income	-14.60M
EPS	-0.05
Shares Out	320.55M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	989,752
Open	0.0400
Previous Close	0.0350
Day's Range	0.0400 - 0.0500
52-Week Range	0.0250 - 0.1500
Beta	2.43
Analysts	n/a
Price Target	n/a
Earnings Date	Feb 27, 2026

About Numinus Wellness

Numinus Wellness Inc. provides psychedelic-assisted therapy training, lab testing, and psychotherapy services in Canada and the United States. The company operates through Clinical Research Operations and Practitioner Training segments. It also provides clinical research management services to academic institutions and biotechnology companies. In addition, the company engages in the provision of education and training for research and drug development organizations to support clinical trials and commercialization efforts. Numinus Wellness Inc. ...

• Industry: Medical Care Facilities
• Sector: Healthcare
• Founded: 1964
• Country: Canada
• Stock Exchange: Toronto Stock Exchange
• Ticker Symbol: NUMI

Financial Performance

In fiscal year 2024, Numinus Wellness's revenue was 4.17 million, an increase of 11.08% compared to the previous year's 3.75 million. Losses were -19.64 million, -35.08% less than in 2023.

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Apr 24, 2026

Data Sources Report a data error